Evidence map›Paper›PMID 40771655›Full record

ReviewPatient preference and adherence2025

Generative AI/LLMs for Plain Language Medical Information for Patients, Caregivers and General Public: Opportunities, Risks and Ethics.

Avishek Pal, Tenzin Wangmo, Trishna Bharadia, Mithi Ahmed-Richards, Mayank Bhailalbhai Bhanderi, Rohitbhai Kachhadiya, Samuel S Allemann, Bernice Simone Elger

Abstract readReview
In one paragraph

Review in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Avishek PalInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland.ORCID 0000-0002-2213-3336
Tenzin WangmoInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland.ORCID 0000-0003-0857-0510
Trishna BharadiaPatient Author, The Spark Global, Buckinghamshire, UK.ORCID 0000-0003-3633-729X
Mithi Ahmed-RichardsCurrent Medical Research & Opinion, Taylor & Francis Group, London, UK.ORCID 0009-0008-4718-6128
Mayank Bhailalbhai BhanderiInnomagine Consulting Private Limited, Hyderabad, India.ORCID 0009-0002-1631-1156
Rohitbhai KachhadiyaInnomagine Consulting Private Limited, Hyderabad, India.ORCID 0000-0002-3569-7317
Samuel S AllemannDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.ORCID 0000-0003-4067-9401
Bernice Simone ElgerInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland.ORCID 0000-0002-4249-7399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generative artificial intelligence (gAI) tools and large language models (LLMs) are gaining popularity among non-specialist audiences (patients, caregivers, and the general public) as a source of plain language medical information. AI-based models have the potential to act as a convenient, customizable and easy-to-access source of information that can improve patients' self-care and health literacy and enable greater engagement with clinicians. However, serious negative outcomes could occur if these tools fail to provide reliable, relevant and understandable medical information. Herein, we review published findings on opportunities and risks associated with such use of gAI/LLMs. We reviewed 44 articles published between January 2023 and July 2024. From the included articles, we find a focus on readability and accuracy; however, only three studies involved actual patients. Responses were reported to be reasonably accurate and sufficiently readable and detailed. The most commonly reported risks were oversimplification, over-generalization, lower accuracy in response to complex questions, and lack of transparency regarding information sources. There are ethical concerns that overreliance/unsupervised reliance on gAI/LLMs could lead to the "humanizing" of these models and pose a risk to patient health equity, inclusiveness and data privacy. For these technologies to be truly transformative, they must become more transparent, have appropriate governance and monitoring, and incorporate feedback from healthcare professionals (HCPs), patients, and other experts. Uptake of these technologies will also need education and awareness among non-specialist audiences around their optimal use as sources of plain language medical information.

Indexed as

artificial intelligenceethicshealth literacylarge language modelplain language summary

Identifiers

PMID40771655
PMCPMC12325106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.